Curse and blessing: upregulation of oncogenes upon treatment with hypomethylating agents in myelodysplastic syndrome
Main Authors: | Juliane Grimm, Mascha Binder |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-022-01143-3 |
Similar Items
-
Babel: curse or blessing?
by: Reynolds, M
Published: (2019) -
Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure
by: Abigail Belasen, et al.
Published: (2020-07-01) -
P760: PATTERNS OF HYPOMETHYLATING AGENT FAILURE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
by: K. Chien, et al.
Published: (2022-06-01) -
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes
by: Nathan Radakovich, et al.
Published: (2022-10-01) -
Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents
by: Sangmin Lee, et al.
Published: (2022-08-01)